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BALB/c 3T3 cell line
Jing Zou1,3*, Hao Feng1, Marika Mannerström2, Tuula Heinonen2 and Ilmari Pyykkö1Abstract
Background: Silver nanoparticles (AgNPs) displayed strong activities in anti-bacterial, anti-viral, and anti-fungal
studies and was reportedly efficient in treating otitis media .The potential impact of AgNPs on the inner ear was
missing.
Objective: Attempted to evaluate the potential toxicity of AgNPs in the inner ear, middle ear, and external ear
canal after transtympanic injection in rats.
Results: In in vitro studies, the IC50 for AgNPs in neutral red uptake assay was lower than that in NAD(P)H-dependent
cellular oxidoreductase enzyme assay (WST-1) and higher than that in total cellular ATP and nuclear membrane
integrity (propidium iodide) assessments. In in vivo experiments, magnetic resonance imaging (MRI) showed that
significant changes in the permeability of biological barriers occurred in the middle ear mucosa, the skin of the external
ear canal, and the inner ear at 5 h post-transtympanic injection of AgNPs at concentrations ranging from 20 μg/ml to
4000 μg/ml. The alterations in permeability showed a dosage-response relationship, and were reversible. The auditory
brainstem response showed that 4000 μg/ml AgNPs induced hearing loss with partial recovery at 7 d, whereas 20 μg/
ml caused reversible hearing loss. The functional change in auditory system was in line with the histology results. In
general, the BALB/c 3T3 cell line is more than 1000 times more sensitive than the in vivo studies. Impairment of the
mitochondrial function was indicated to be the mechanism of toxicity of AgNPs.
Conclusion: These results suggest that AgNPs caused significant, dose-dependent changes in the permeability of
biological barriers in the middle ear mucosa, the skin of the external ear canal, and the inner ear. In general, the BALB/c
3T3 cell line is more than 1000 times more sensitive than the in vivo studies. The rat ear model might be expended to
other engineered nanomaterials in nanotoxicology study.
Keywords: Animal model, Biological barrier, Ear, Imaging, NanomaterialBackground
Chronic otitis media, characterized by recurrent infec-
tions causing pain and purulent otorrhea, is still a
significant public health problem affecting 0.5–30% of
any given population in developing and developed coun-
tries. However, antibiotic is not always efficient because
of the appearance of multidrug resistant strains of bac-
teria. Formation of biofilm was recently reported in the
middle ear of patients with chronic otitis media all over* Correspondence: Jing.Zou@uta.fi
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unless otherwise stated.the world [1-4]. Silver nanoparticles (AgNPs) displayed
strong activities in anti-bacterial, anti-viral, and anti-
fungal studies attributed to the mechanisms of inhibiting
the formation of biofilm and destroying viral structures
and boosting innate immune response among others
[5-9]. The medical applications of AgNPs include surgi-
cal fields, such as urology, dentistry, general surgery and
orthopedics, and wound dressing to take advantage of
good antibacterial activity [10]. Therefore, AgNPs will
potentially be selected as an alternative strategy to treat
diseases in the ear by combating biofilm formation and
any potential multidrug resistant strains of bacteria that
is big challenge for conventional antibiotics. A clinical
study on treatment of relapses of chronic suppurative
otitis media showed that a preparation containing silver. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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dynamics of the objective signs of the disease, such as
reduction or termination of pathological exudation and
stimulation of the epidermization processes, which was
stable during the observation time of 6 months [11].
However, before formal application in the clinic practice,
sophisticated toxicological study on AgNPs in the inner
ear to evaluate any potential risk of the new agent is
necessary.
In vivo rodent studies have shown that AgNPs induce
liver and neural toxicity after intravenous injection [12].
The neural toxicity in the brain is suspected to be the re-
sult of the passage of AgNPs across and breaking down
the blood–brain barrier [13]. Biological barriers are de-
fined as a membrane, tissue, or mechanisms that select-
ively transport certain substances into the tissue and
block others. Previous work showed that a rat’s inner ear
has also a sophisticated barrier system isolating different
compartments as well as the engineered nanomaterials
distributed in the inner ear after middle ear administra-
tion [14-17]. This membranous barrier system in the
inner ear is similar to that in the brain and the func-
tional changes in the barriers resulting from hazardous
exposure can be evaluated using MRI with high accuracy
[18,19]. The auditory function alteration caused by toxic
substances can also be measured accurately, which is
otherwise inconvenient in the brain or cranial nerves
[15,20]. The blood-endolymph and blood-perilymph bar-
riers control the interaction between the inner ear and
blood. The blood-perilymph barrier is permeable to
certain small molecules and is similar to that of cerebro-
spinal fluid, with minor variations [21-23]. The blood-
endolymph barrier is as tight as the blood–brain barrier
and does not allow the MRI contrast agent, gadolinium
chelate, to pass through under physiological conditions
[24,25]. AgNPs may pass through and impair these bar-
riers in the inner ear. In addition, the skin in the exter-
nal ear canal and mucosa in the middle ear cavity are
also exposed to AgNPs when the agent is delivered to
the external ear canal to treat otitis media. Transtympa-
nic injection of AgNPs in rats can mimic the clinical
application and the animal suffering is minor. This
multifunctional rat ear model can also be utilized for
evaluating potential toxicity of other types of engineered
nanomaterials with a focus on the impacts on the bio-
logical barriers in the skin (external ear canal), mucosa
(middle ear cavity), nerve system (inner ear).
In the work presented here, in vitro study was per-
formed in the BALB/c 3T3 cell line that were exposed to
AgNPs for 24 h, a longer exposure time than the literature
report in order ensure adequate toxicity [26]. Using the neu-
tral red uptake (NRU) assay which is an in vitro evaluation
of acute mammalian toxicity accepted by Organization
for Economic Cooperation and Development (OECDGD 129, 2010) [27] (http://www.alttox.org/ttrc/validation-
ra/validated-ra-methods.html). The NRU study was fur-
ther compared with three other cytotoxicity assays
with different end points: NAD(P)H-dependent cellu-
lar oxidoreductase enzyme assay (WST-1) for evaluat-
ing the mitochondrial function (which produces a
water-soluble formazan, reacts with the mitochondrial
respiratory Complex II, and is more stable than con-
ventional MTT assay) [28], the total cellular ATP
measurement as a general indicator of mitochondrial
activity, and the propidium iodide staining for asses-
sing the nuclear membrane integrity that are alterna-
tive methods. Cytotoxicity of AgNPs was compared
with AgCl (in the case of Ag+ release, AgCl is the
major product in the body), as well as AgNO3 as a ma-
terial control that was reported in the literature [29].
In vivo experiments were carried out in rats after
transtympanic injection of either AgNPs, or solution
of AgNO3 or AgCl. Functional changes in the blood-
inner ear barriers, as well as in the capillary barriers in
the skin of the external ear canal and mucosa of the
middle ear cavity, were evaluated using gadolinium-
enhanced magnetic resonance imaging (MRI). Auditory
function was monitored by the auditory brainstem re-
sponse (ABR) measurement. The potential cell death of
different cellular populations in the cochlea was analyzed.
Results
Comparison of AgNP toxicity in BALB/c 3T3 cells between
NRU and other end points
The IC50 for AgNPs was 2.8 μg/ml in NRU assay, which
was lower than that in WST-1 and higher than that in
total cellular ATP and nuclear membrane integrity (pro-
pidium iodide) assessments (Figure 1, Table 1). There
was a significant (P < 0.001) ~50% increase in mitochon-
drial activity of BALB/c 3T3 cells at AgNP concentration
2.1 μg/ml (shown by WST-1). Thereafter the viability
dropped steeply. Other cytotoxicity assays showed no
such increase in viability compared to control value (un-
treated cells). The IC50 for AgNO3 was lower than that
for the AgNPs in all the measurement methods. How-
ever, AgCl up to saturated concentration was insignifi-
cantly toxic.
Permeability change of the biological barriers in rat ear
after AgNP exposure
Significant changes in the permeability of the biological
barriers occurred in the middle ear mucosa, skin of the
external ear canal, and the inner ear at 5 h post-
transtympanic injection at concentrations ranging from
20 μg/ml to 4000 μg/ml. The induced permeability alter-
ation showed a dosage-response relationship and recovered
to base line in barriers in the middle ear mucosa, external
ear canal skin, and the inner ear except vestibule, that only
Figure 1 Cytotoxicity of AgNPs, AgNO3, and AgCl in BALB/c 3T3 cells shown by NRU, WST-1, total cellular ATP, and nuclear membrane
integrity assessments. −• − AgNPs, −-Δ– AgNO3 solution, −-■ – AgCl solution.
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lower than 4000 μg/ml of Ag NPs (Figures 2 and 3).
The impact of AgNP exposure on the auditory function
of rats
ABR is an auditory evoked potential extracted from on-
going electrical activity in the brain and recorded withTable 1 IC50 of AgNPs and AgNO3 evaluated in BALB/c
3T3 cells using NRU, WST-1, ATP, and PI methods
Assay IC50 (μg/ml) and coefficient of determination (R
2)
AgNPs AgNO3
IC50 R
2 IC50 R
2
NRU 2.8 0.97 1.9 0.97
WST-1 3.0 0.86 2.0 0.93
ATP 2.6 0.96 1.5 0.95
PI 2.2 0.80 1.4 0.78
ATP, total ATP measurement; NRU, neutral red uptake assay; PI, propidium
iodide penetration assay; WST-1, NAD(P)H-dependent cellular oxidoreductase
enzyme assay.subcutaneous platinum needle electrodes placed in the
scalp. The resulting recording is a series of vertex posi-
tive waves of which I through V are evaluated. The wave
II is the most evident and stable response in rats and
utilized to identify the threshold which is the minimum
visible and repeatable response. The hearing loss level
was presented as threshold shift in the ABR measure-
ment, which is that the larger the threshold shift the
more severe the hearing loss. The increase in this par-
ameter indicates the degree of hearing loss that is
expressed by decibel (dB). Figure 4 showed the induced
hearing loss in rats. At 2 d post-transtympanic injection,
the AgNPs at a concentration of 4000 μg/ml caused sig-
nificant threshold shifts of 29 dB upon click stimuli and
from 18 dB to 32 dB with tone burst stimuli at frequen-
cies of 2 kHz, 4 kHz, 8 kHz, 16 kHz, and 32 kHz (p <
0.01, independent sample t-test); however, AgNPs at a
concentration of 200 μg/ml caused only a significant
threshold shift of 16 dB at 32 kHz (p < 0.01, independent
sample t-test). On 4 d post-transtympanic injection,
Figure 2 Gd-contrasted MRI showed that dynamic changes in the permeability of the biological barriers occurred in the middle ear
mucosa, skin of the external ear canal, and the inner ear after exposure to 400 μg/ml AgNPs. Figures a and b are measured 5 h after
exposure and figures c and d 7 d after exposure. Quantification data was shown in Figure 3. Coch: cochlea; MEI: middle ear infiltration; MEM:
middle ear mucosa; SM: scala media; ST: scala tympani; SV: scala vestibuli; Vest: vestibulum.
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cant threshold shifts of 19 dB upon click stimuli and
from 14 dB to 35 dB on tone burst stimuli at frequencies
of 2 kHz, 4 kHz, 8 kHz, 16 kHz, and 32 kHz (p < 0.01,
independent sample t-test). The threshold shift induced
by AgNPs at a concentration of 200 μg/ml reduced to
4 dB at 32 kHz but remained significant (p < 0.01, inde-
pendent sample t-test). At 7 d post-transtympanic injec-
tion, AgNPs at a concentration of 4000 μg/ml caused no
significant threshold shifts upon click stimuli and toneFigure 3 Quantifications on AgNP induced permeability changes in th
by Gd-DOTA-enhanced MRI. a. Results on d 0. b. Results on d 7. *p < 0.05
SV: scala vestibule; vest: vestibule.burst stimuli at a frequency of 2 kHz, but significant
threshold shifts from 5 dB to 33 dB at frequencies of
4 kHz through 32 kHz were observed (p < 0.01, inde-
pendent sample t-test). No significant threshold shift
was detected in rats exposed to AgNPs at a concentra-
tion of 200 μg/ml. There was a significant positive linear
correlation between the threshold shift and frequency in
rats exposed to AgNPs at a concentration of 4000 μg/ml
at the observation time points of 2 d, 4 d, and 7 d (p <
0.01, 2-tailed Pearson correlation).e biological barriers in the skin, mucosa, and inner ear shown
; **p < 0.01(independent t-test). SM: scala media; ST: scala tympani;
Figure 4 The threshold shifts in the rats caused by the
transtympanic injection of the AgNPs are shown by auditory
brainstem response (ABR) measurements. 40 μl of either AgNPs
at different concentrations or water were delivered into the middle
ear via transtympanic injection. The ABR were measured before and
after injection at defined time points. The threshold shift = the
threshold post injection-threshold pre-injection. cl: click. **p < 0.01
(independent sample t-test).
Figure 5 DNA fragmentation in the inner ear cells at 7 d post-exposu
cells in the vestibule (a, b), stria vascularis (d-f), Reissner’s membrane (RM)
higher turn (Coch-LW2ndH), limited marginal cells (StrMC) in the stria vascu
fragmentation (f). 200 μg/ml AgNP caused DNA fragmentation in cells in o
and hair cells of the cochlear Corti’s organ (Coch-CO)(G). Water did not cau
demonstrated in the negative control by omitting the labeling solution. Pe
b, c, d, and E respectively. Coch-LW1stL: lateral wall of the cochlear lower b
Coch-LW2ndH: lateral wall of the cochlear higher second turn; Enth: endot
ampulla in the vestibule; Vest-Sa: saccule in the vestibule. Scale bars = 24.8
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Inner ear cell death (apoptosis) was detected in the inner
ear exposed to AgNPs at concentrations of both 200 μg/
ml and 4000 μg/ml, as indicated by DNA fragmentation.
In general, greater cell death occurred in the vestibule
than in the cochlea. This was more obvious at the lower
concentration of AgNPs. In the cochlea, the strial mar-
ginal cells were among the most sensitive cells to de-
velop apoptosis after AgNP exposure, and were followed
by the osteocytes in the cochlear shell, the osseous spiral
limbus, epithelial cells of the Reissner’s membrane, the
spiral ligament fibrocytes, the spiral ganglion satellite
cells, endothelial cells and pericytes of the cochlea capil-
laries, and cochlear hair cells. At 4000 μg/ml of AgNPs,
there was universal cell death in the vestibule end organ
and cochlea, between the hook region and the second
lower turn, as well as the Reissner’s membrane, part of the
spiral ganglion, sparse stria vascularis, spiral ligament, ca-
pillary, and osseous spiral limbus from the second higher
turn to the apex. At 200 μg/ml AgNPs, there was cell
death in most the vestibular end organ cells, and cochlear
cell populations, which was similar to that caused by
4000 μg/ml AgNPs in the higher turns (Figure 5).re to the AgNPs. 4000 μg/ml AgNP caused DNA fragmentation in the
(d, f), and spiral ligament (SL in d-f). In the lateral wall of second
laris and sparse fibrocytes in the spiral ligament (SL) showed DNA
sseous spiral lamina (OSL in h), cells in the cochlear capillary (Cap in I),
se significant DNA fragmentation in the vestibule (c). No staining was
rcentages of positive staining were 74%, 66%, 0%, 53%, and 59% in a,
asal turn; Coch-LW2ndL: lateral wall of the cochlear lower second turn;
helial cells; Epth: epithelial cells; PC: pericytes of the Cap; Vest-Am:
μm in a-f, h, j, and 10 μm in g and i.
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MRI results showed that the biological barriers in the
skin, mucosa, and inner ear of rats were opened by the
AgNPs in a dose-dependent manner, which was sup-
ported by histology. Changes in the biological barrier
function of the ear were reversible in rats exposed to
AgNPs at tested concentrations. The biological barriers
impede the passage of substances as nanoparticles into
the tissue and protect the organ so that it can function
properly. Hence, they constrain the bioavailability of
AgNPs. As the direct contact site, the barrier in the mid-
dle ear mucosa is the most accessible structure observed
in the MRI study. The middle ear mucosa is a direct
continuation of the mucosa of the upper respiratory
tract; data acquired in the middle ear mucosa is relevant
to explaining the impact of AgNPs on the respiratory
mucosa, including the nasal mucosa.
After passing through the barriers of the round and
oval windows, AgNPs entered the inner ear and dis-
rupted the blood-perilymph and blood-endolymph bar-
riers, causing hearing loss. Greater cell death in the
vestibule than that in the cochlea indicated that the oval
window is more permeable to AgNPs than the round
window which is in accordance with the phenomenon
observed in gadolinium transport from the middle ear to
the inner ear [30]. However, no balance problem was
observed in the animals exposed to any of these concen-
trations of AgNPs (data will be reported separately).
Although AgNPs may directly damage the sensorineural
cells in the inner ear, complete recovery of hearing loss
induced by 200 μg/ml AgNPs suggested that most of the
inner and outer hair cells and spiral ganglion cells are
preserved, and hearing loss is mainly due to destabilized
ion homeostasis [18,31,32]. The blood-endolymph bar-
rier was rather resistant to AgNPs, suggesting that the
blood-endolymph barrier integrity is critical to maintain-
ing hearing function.
The present study showed that individual cells in vitro
are more sensitive to AgNPs than the inner ear cells
in vivo. It is in accordance with a previous study show-
ing that individual primary cochlear cells are more sensi-
tive to the mitochondrial toxin, 3-nitropropionic acid
(3NP), than the cells in the cochlea of living guinea pigs
[33]. In the present study, AgNP caused BALB/c 3T3 cell
death with IC50 values ranging from 2.2 to 3.0 μg/ml, as
determined by measuring the NAD(P)H-dependent cellu-
lar oxidoreductase enzyme activity (WST-1), total cellular
ATP, nuclear membrane permeability (propidium iodide),
and NRU. The observed significant increase in mitochon-
drial activity of BALB/c 3T3 cells at AgNP concentration
2.1 μg/ml without alteration in ATP levels indicated that
the net ATP level might be affected by several activities.
We suspect that an augmented cellular activity accompany
an increased mitochondrial activity and the cells consumemore ATP giving rise to a stable cellular ATP level as pre-
sented in the data. This indicates that WST-1 assay is a
more sensitive and reliable parameter of cellular viability
than measuring the ATP level. Therefore, WST-1 assay
was selected for inter-laboratory validation in nanotoxicol-
ogy of European Commission FP7 large-scale integrating
project NanoValid (internal data) [34]. The IC50 for AgNO3
was lower than that for AgNPs. It has been reported that
both AgNPs and ionic Ag+ (using AgNO3 as material con-
trol) are toxic to the cells [29]. This is actually doubtful be-
cause no AgNO3 remains in either the animal or human
body after administration because AgNO3 reacts with saline
and is converted to AgCl and NO−3 in plasma (and medium
in the cell culture). It is well known that NO−3 ion is
extremely toxic to any cells. If Ag+ is released from the
AgNPs, the major product is AgCl, which has low water
solubility. In the present study AgCl was, indeed, insignifi-
cantly toxic to the BALB/c 3T3 cells tested up to the satu-
rated concentration. To correlate with in vitro studies,
200 μg/ml AgNPs induced reversible changes in the bio-
logical barrier and auditory functions. The dose of 4000 μg/
ml AgNPs caused hearing loss (with partial recovery). In
general, the IC50 in the present in vitro tests are more than
1000 times more sensitive than the in vivo studies, which is
most likely attributed to the protective function of the
highly regulated double layer of the biological barriers (the
oval and round windows, and the endolymph barrier in the
inner ear) and the extracellular matrix.
The hearing measurement was in line with the cell death
observed in histology. At a dose of 200 μg/ml, AgNPs
caused a reversible hearing loss at 32 kHz, correlating with
the lower basal turn of the cochlea. This is in accordance
with the cell death map (Figure 5). A dose of 4000 μg/ml
AgNPs caused irreversible hearing loss above 8 kHz,
matching the broadly distributed cell death up to the sec-
ond lower turn (Figure 5) [35]. However, only partial hear-
ing loss occurred at the frequencies of 16 kHz and 32 kHz
instead of total loss on day 7. Our explanation for this dis-
parity is that spatial information on Corti’s organ dysfunc-
tion provided by tone burst ABR is much less accurate
than the histology. It is known that the tone burst, which
has relatively broad spectra, also elicits a response from a
region of intact Corti’s organ that is distant from the nom-
inal stimulus frequency and causes a false positive result
[36]. Therefore, the 16 kHz and 32 kHz stimuli elicited
nerve fibers that are responsible for higher tone hearing
where the Corti’s organs did not show any impairment at
the higher turns when the Corti’s organs at their specific
frequency were damaged.
The vestibular cells demonstrated greater impair-
ment than the cochlear cells after exposure to AgNPs
at a low concentration, indicating that the passage of
AgNPs into the vestibule through the oval window
might be more efficient than the passage into the
Zou et al. Journal of Nanobiotechnology 2014, 12:52 Page 7 of 10
http://www.jnanobiotechnology.com/content/12/1/52cochlea through the round window because AgNP in-
duced cellular toxicity is concentration-dependent, as
shown in the in vitro study. However, this hypothesis
needs to be tested in future studies.
Our results suggest that the AgNPs impaired mito-
chondrial function through inhibition of the mitochon-
drial succinate-tetrazolium reductase activity (shown by
WST-1) and ATP production. The notable ~50% in-
crease in mitochondrial activity (as shown by WST-1) at
2.1 μg/ml prior to its ~50% reduction at 3.0 μg/ml indi-
cated the onset of defense process upon AgNP stimuli,
i.e., hormesis (other cytotoxicity assays did not show any
increase at this concentration) and further supported the
occurrence of oxidative stress within the mitochondria
[37]. These results also support the previously reported
findings that showed that mitochondrial dysfunction is
involved in hearing loss by causing energy shortage. The
sensitivity of different cell populations to mitochondrial
toxins is determined by the cellular activity-related
energy consumption [18,33]. The cells that are impaired
in the blood-perilymph and blood-endolymph barriers
after the delivery of AgNPs are among the sensitive
populations. A comprehensive gene sequencing study in
zebrafish embryos demonstrated that the most notably
affected gene pathway by silver in the nano-, bulk-, and
ionic forms is associated with oxidative phosphorylation
and protein synthesis [38]. The mitochondria is the site
of oxidative phosphorylation, and AgNPs disrupt mito-
chondrial membrane permeability as well as decrease
the activity of the mitochondrial respiratory chain com-
plexes I, II, III, and IV in cells from the brain, skeletal
muscle, heart, and liver of rats [39,40]. Specifically,
AgNPs induced apoptosis in NIH3T3 cells was report-
edly associated with the generation of reactive oxygen
species (ROS) and Jun amino-terminal kinases (JNK)
activation, leading to the release of cytochrome C into
the cytosol and translocation Bax to mitochondria [26].
Consequently, the cell death of BALB/c 3T3 cells in-
duced by AgNPs in the present study was associated
with the disrupted integrity of the nuclear membrane,
which was visible by propidium iodide staining.
In conclusion, AgNPs caused significant, dose-dependent
changes in the permeability of biological barriers in the
middle ear mucosa, the skin of the external ear canal, and
the inner ear. The functional change in the auditory systemTable 2 Assignments of rats in MRI and ABR measurements p
Measures Number of rats exposured to varied concentration of A
4000 μg/ml 200
5 h 2 d 4 d 7 d 5 h
MRI 2 - - 2 7
ABR - 7 7 7 -
*Three rats receiving 400 μg/ml AgNP injection were pooled in the 200 μg/ml grouwas in line with the histology results. In general, the BALB/
c 3T3 cell line is more than 1000 times more sensitive than
the in vivo studies. Impairment of the mitochondrial func-
tion was indicated to be the toxic mechanism caused by the
AgNP exposure. These results suggest that the concentra-
tion of AgNPs should be tightly controlled in clinic applica-
tion in treating otitis media. The rat ear model might be
expended to other engineered nanomaterials in nanotoxi-
cology study.
Materials and methods
The polyvinylpyrrolidone stabilized AgNPs was supplied
by Colorobbia (Firenze, Italy). The AgNPs were dis-
persed in deionized water (40 mg/ml) and scanning elec-
tron microscopy showed that the AgNPs are spheroids
in morphology with a particle size of around 100 nm.
Dynamic light scattering (DLS) showed a mean hydro-
dynamic size of 117 ± 24 nm and a mean zeta potential
of −20 ± 9 mV. The selected AgNPs is stable in artificial
perilymph which is the main solution in the inner ear
that AgNPs would interact (data including the full
characterization data will be published separately).
The murine fibroblast cell line BALB/c 3T3 clone 31 was
purchased from ATCC (American Type Culture Collection,
LGC Promochem AB, Boras, Sweden). Dulbecco’s Modifica-
tion of Eagle’s Medium (DMEM), L-glutamine, and new-
born calf serum (NBCS) were purchased from Gibco
Invitrogen (Carlsbad, USA). Stability of the AgNPs in the
DMEM is still under inverstigation between several laboratory
in Europe within the European Union 7th frame programme
(EU FP7) large-scale integrating project NanoValid [34]
(http://cordis.europa.eu/result/rcn/140307_en.html). An ATP
Determination Kit was purchased from Life Technologies
(California, USA). WST-1 and an In Situ Cell Death Detec-
tion Kit (TMR red) were purchased from Roche (Basel,
Switzerland). Propidium iodide, paraformaldehyde (PFA),
4,6-diamidino-2-phenylindole (DAPI), and Fluoromoun™
were purchased from Sigma-Aldrich (St. Louis, USA).
Fourteen male Sprague Dawley rats for the MRI study,
weighing between 287 g and 524 g, were maintained in the
Biomedicum Helsinki, Laboratory Animal Centre, Univer-
sity of Helsinki. Fourteen male Sprague Dawley rats for
ABR measurements weighing between 330 g and 410 g,
were maintained in the Experimental Animal Unit, School
of Medicine, University of Tampere, Finland (Table 2). Allost-intratympanic administration of AgNPs
gNPs for different time
μg/ml* 2000 μg/ml
2 d 4 d 7 d 5 h 7 d
- - - 5 5
7 7 7 - -
p in MRI study. ABR: auditory brainstem response. -: no exposure.
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mittee of University of Tampere (permission: ESAVI/3033/
04.10.03/2011). Animal care and experimental procedures
were conducted in accordance with European legislation.
Animals for the MRI study were anesthetized with isoflur-
ane with a 5% isoflurane–oxygen mixture (flow-rate 1.0 L/
min) for induction and 3% for maintenance via a facemask.
The ABR measurements were performed under general
anesthesia after the intraperitoneal injection of a mixture of
0.8 mg/kg of medetomidine hydrochloride (Domitor, Orion,
Espoo, Finland) and 80 mg/kg of ketamine hydrochloride
(Ketalar; Pfizer, Helsinki, Finland). During the experiments,
Viscotears® (Novartis Healthcare A/S, Denmark) were used
to protect the animals’ eyes.
BALB/c 3T3 cells were cultured in DMEM containing
4 mM L-glutamine and supplemented with 10% NBCS
at 37°C with 5% CO2; they were then seeded to 96-well
plates at a density of ~3000 cells/well and allowed to
form a 50-70% confluent monolayer after 24 ± 2 h. For
the propidium iodide assays, 96-well black plates with
clear bottoms were used. After replacing the medium
with 90 μl DMEM containing 4 mM L-glutamine and
5% NBCS, 10 μl AgNP dilutions (prepared immediately
prior to use in deionized water) were added to the wells
to reach eight different AgNP and AgNO3 (final concen-
trations 0.67-10.0 μg/ml) and six different AgCl (final
concentrations 0.0052-5.2 μg/ml) concentrations with 6
replicates. The plates were then incubated for 24 h. The
exposure time was defined according the results showing
that AgNPs remained in rat cochlear for at least 24 h
after transtympanic injection (unpublished data acquired
using micro computed tomography). The medium con-
taining 10% deionized water was used as a vehicle control.
Four different assays were used to study the viability of
BALB/c 3T3 cells after AgNP exposure, which are NRU,
WST-1, the total cellular ATP, and propidium iodide stain-
ing. Each assay was performed twice (Additional file 1:
Support material 1).
Under general anesthesia, 40–50 μl of AgNPs at de-
fined concentrations were injected into the left middle
ear cavity through the tympanic membrane penetration
under an operating microscope (Table 2). After injection,
the animals were kept in the lateral position with the
injected ear oriented upward for 15 min before further
measurements.
A 4.7 T MR scanner with a bore diameter of 155 mm
(PharmaScan, Bruker BioSpin, Germany) was used in the
MR measurements for evaluation of the biological barrier
function in the ear. The maximum gradient strength was
300 mT/m with an 80-μs rise time. A gadolinium-tetra-
azacyclo-dodecane-tetra-acetic acid (Gd-DOTA, 500 mM,
DOTAREM, Guerbet, Cedex, France) solution was injected
into the tail vein at a dosage of 0.725 mM/kg 2 h before the
MRI measurements. MRI scanning commenced at severaltime points after the transtympanic injection. The first MRI
time of 5 h was determined by taking the penetration time
of liposome nanoparticles from the middle ear to the inner
ear as a reference [16]. The final imaging time of 7 d was
selected according to the course of acute inflammation. For
imaging protocols, refer to the Additional file 1: Support
material 2.
BioSig32 (Tucker Davis Technologies, Florida, USA)
was used for the ABR threshold recording in rats in a
custom made, soundproof chamber. Both click and tone
burst stimuli were used for the ABR measurements at
a certain time point post-administration of AgNPs. The
first ABR measurement was followed on 2 d post-
administration of AgNPs allowing the animals to recover
from the general anesthesia during the injection and en-
sure the injected solution to be entirely cleared from the
middle ear cavity. The second follow-up time of 4 d post-
injection was chosen because it is close to the peak time
of mitochondrial toxin-induced cell death in the cochlea
[33]. The third follow-up time of 7 d is the period of acute
inflammation. For details on the ABR recording, refer to
the Additional file 1: Support material 3.
For nuclear DNA fragmentation analysis in rat coch-
lea, animals were perfused with 4% PFA in 0.1 M PBS
(pH 7.4) following cardiac perfusion and the removal of
the blood with 50 mL physiological saline containing
0.3 mL heparin (100 IE). The bullae were collected and
fixed with 4% PFA overnight and processed for nuclear
DNA fragmentation investigation using terminal trans-
ferase (TdT) to label the free 3’OH breaks in the DNA
strands of apoptotic cells with TMR-dUTP. For details
on the analysis, refer to the Additional file 1: Support
material 4.
Additional file
Additional file 1: Support materials 1-4.
Abbreviations
ABR: Auditory brainstem response; AgNPs: Silver nanoparticles; DAPI:
4,6-diamidino-2-phenylindole; DMEM: Dulbecco’s Modification of Eagle’s
Medium; Gd-DOTA: Gadolinium-tetra-azacyclo-dodecane-tetra-acetic acid;
JNK: Jun amino-terminal kinases; MRI: Magnetic resonance imaging;
NBCS: Newborn calf serum; NRU: Neutral red uptake; OECD: Organization
for Economic Cooperation and Development; PFA: Paraformaldehyde;
ROS: Reactive oxygen species; TdT: Terminal transferase.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
Conceived and designed the experiments: JZ MM TH IP. Performed the
experiments: JZ HF MM. Analyzed the data: JZ HF MM. Wrote the paper:
JZ MM. All authors read and approved the final manuscript.
Acknowledgements
The authors gratefully acknowledge financial support from European
Community FP7 large-scale integrating project NanoValid (contract: 263147).
Zou et al. Journal of Nanobiotechnology 2014, 12:52 Page 9 of 10
http://www.jnanobiotechnology.com/content/12/1/52The authors also want to thank Lesley Tobin de Fuentes (Institute of Nano-
technology, UK) for proofreading the manuscript.
Author details
1Hearing and Balance Research Unit, Field of Oto-laryngology, School of
Medicine, University of Tampere, Tampere, Finland. 2The Finnish Centre for
Alternative Methods, School of Medicine, University of Tampere, Tampere,
Finland. 3Department of Otolaryngology-Head and Neck Surgery, Center for
Otolaryngology-Head & Neck Surgery of Chinese PLA, Changhai Hospital,
Second Military Medical University, Shanghai, China.
Received: 17 August 2014 Accepted: 12 November 2014
References
1. Hall-Stoodley L, Hu FZ, Gieseke A, Nistico L, Nguyen D, Hayes J, Forbes M,
Greenberg DP, Dice B, Burrows A, Wackym PA, Stoodley P, Post JC, Ehrlich
GD, Kerschner JE: Direct detection of bacterial biofilms on the middle-ear
mucosa of children with chronic otitis media. JAMA 2006, 296(2):202–211.
2. Wessman M, Bjarnsholt T, Eickhardt-Sorensen SR, Johansen HK, Homoe P:
Mucosal biofilm detection in chronic otitis media: a study of middle ear
biopsies from Greenlandic patients. Eur Arch Otorhinolaryngol 2014.
3. Gu X, Keyoumu Y, Long L, Zhang H: Detection of bacterial biofilms in
different types of chronic otitis media. Eur Arch Otorhinolaryngol 2013
4. Nguyen CT, Robinson SR, Jung W, Novak MA, Boppart SA, Allen JB:
Investigation of bacterial biofilm in the human middle ear using optical
coherence tomography and acoustic measurements. Hear Res 2013,
301:193–200.
5. Sawada I, Fachrul R, Ito T, Ohmukai Y, Maruyama T, Matsuyama H:
Development of a hydrophilic polymer membrane containing silver
nanoparticles with both organic antifouling and antibacterial properties.
J Membr Sci 2012, 387–388:1–6.
6. Doudi M, Naghsh N, Setorki M: Comparison of the effects of silver
nanoparticles on pathogenic bacteria resistant to beta-lactam antibiotics
(ESBLs) as a prokaryote model and Wistar rats as a eukaryote model.
Med Sci Monit Basic Res 2013, 19:103–110.
7. Lu Z, Rong K, Li J, Yang H, Chen R: Size-dependent antibacterial activities
of silver nanoparticles against oral anaerobic pathogenic bacteria.
J Mater Sci Mater Med 2013, 24(6):1465–1471.
8. Pinto RJ, Almeida A, Fernandes SC, Freire CS, Silvestre AJ, Neto CP, Trindade
T: Antifungal activity of transparent nanocomposite thin films of pullulan
and silver against Aspergillus niger. Colloids Surf B Biointerfaces 2013,
103:143–148.
9. Xiang D, Zheng Y, Duan W, Li X, Yin J, Shigdar S, O'Connor ML, Marappan
M, Zhao X, Miao Y, Xiang B, Zheng C: Inhibition of A/Human/Hubei/3/
2005 (H3N2) influenza virus infection by silver nanoparticles in vitro and
in vivo. Int J Nanomedicine 2013, 8:4103–4113.
10. You C, Han C, Wang X, Zheng Y, Li Q, Hu X, Sun H: The progress of silver
nanoparticles in the antibacterial mechanism, clinical application and
cytotoxicity. Mol Biol Rep 2012, 39:9193–9201.
11. Semenov FV, Fidarova KM: The treatment of the patients presenting with
chronic inflammation of the trepanation cavity with a preparation
containing silver nanoparticles following sanitation surgery of the open
type. Vestn Otorinolaringol 2012, 6:117–119.
12. Kim YS, Song MY, Park JD, Song KS, Ryu HR, Chung YH, Chang HK, Lee JH,
Oh KH, Kelman BJ, Hwang IK, Yu IJ: Subchronic oral toxicity of silver
nanoparticles. Part Fibre Toxicol 2010, 7:20.
13. Sharma HS, Hussain S, Schlager J, Ali SF, Sharma A: Influence of
nanoparticles on blood–brain barrier permeability and brain edema
formation in rats. Acta Neurochir Suppl 2010, 106:359–364.
14. Zou J, Saulnier P, Perrier T, Zhang Y, Manninen T, Toppila E, Pyykko I:
Distribution of lipid nanocapsules in different cochlear cell populations
after round window membrane permeation. J Biomed Mater Res B Appl
Biomater 2008, 87(1):10–18.
15. Zhang Y, Zhang W, Lobler M, Schmitz KP, Saulnier P, Perrier T, Pyykko I, Zou
J: Inner ear biocompatibility of lipid nanocapsules after round window
membrane application. Int J Pharm 2011, 404(1–2):211–219.
16. Zou J, Sood R, Ranjan S, Poe D, Ramadan UA, Kinnunen PK, Pyykko I:
Manufacturing and in vivo inner ear visualization of MRI traceable
liposome nanoparticles encapsulating gadolinium. J Nanobiotechnology
2010, 8:32.17. Zou J, Sood R, Ranjan S, Poe D, Ramadan UA, Pyykko I, Kinnunen PK:
Size-dependent passage of liposome nanocarriers with preserved
posttransport integrity across the middle-inner ear barriers in rats.
Otol Neurotol 2012, 33(4):666–673.
18. Zou J, Li M, Zhang Y, Zheng G, Chen D, Chen S, Zheng H: Transport
augmentation through the blood-inner ear barriers of guinea pigs
treated with 3-nitropropionic acid and patients with acute hearing loss,
visualized with 3.0 T MRI. Otol Neurotol 2011, 32(2):204–212.
19. Counter SA, Bjelke B, Borg E, Klason T, Chen Z, Duan ML: Magnetic
resonance imaging of the membranous labyrinth during in vivo
gadolinium (Gd-DTPA-BMA) uptake in the normal and lesioned cochlea.
Neuroreport 2000, 11(18):3979–3983.
20. Powers BE, Widholm JJ, Lasky RE, Schantz SL: Auditory deficits in rats
exposed to an environmental PCB mixture during development.
Toxicol Sci 2006, 89(2):415–422.
21. Ferrary E, Sterkers O, Saumon G, Tran Ba Huy P, Amiel C: Facilitated transfer
of glucose from blood into perilymph in the rat cochlea. Am J Physiol
1987, 253(1 Pt 2):F59–F65.
22. Sterkers O, Ferrary E, Saumon G, Amiel C: Na and nonelectrolyte entry into
inner ear fluids of the rat. Am J Physiol 1987, 253(1 Pt 2):F50–F58.
23. Zou J, Pyykko I, Counter SA, Klason T, Bretlau P, Bjelke B: In vivo
observation of dynamic perilymph formation using 4.7 T MRI with
gadolinium as a tracer. Acta Otolaryngol 2003, 123(8):910–915.
24. Counter SA, Bjelke B, Klason T, Chen Z, Borg E: Magnetic resonance
imaging of the cochlea, spiral ganglia and eighth nerve of the guinea
pig. Neuroreport 1999, 10(3):473–479.
25. Zou J, Zhang W, Poe D, Zhang Y, Ramadan UA, Pyykko I: Differential
passage of gadolinium through the mouse inner ear barriers evaluated
with 4.7 T MRI. Hear Res 2010, 259(1–2):36–43.
26. Hsin YH, Chen CF, Huang S, Shih TS, Lai PS, Chueh PJ: The apoptotic effect
of nanosilver is mediated by a ROS- and JNK-dependent mechanism
involving the mitochondrial pathway in NIH3T3 cells. Toxicol Lett 2008,
179(3):130–139.
27. Organisation for Economic Co-operation and Development: Guidance
document on using cytotoxicity tests to estimate starting doses for
acute oral systemic toxicity tests. ENV/JM/MONO 2010, 20(No. 129):1–54.
28. Ngamwongsatit P, Banada PP, Panbangred W, Bhunia AK: WST-1-based cell
cytotoxicity assay as a substitute for MTT-based assay for rapid detection
of toxigenic Bacillus species using CHO cell line. J Microbiol Methods 2008,
73(3):211–215.
29. Gagne F, Auclair J, Turcotte P, Gagnon C: Sublethal effects of silver
nanoparticles and dissolved silver in freshwater mussels. J Toxicol Environ
Health A 2013, 76(8):479–490.
30. Zou J, Poe D, Ramadan UA, Pyykko I: Oval window transport of Gd-dOTA
from rat middle ear to vestibulum and scala vestibuli visualized by
in vivo magnetic resonance imaging. Ann Otol Rhinol Laryngol 2012,
121(2):119–128.
31. Zou J, Zhang Y, Yin S, Wu H, Pyykko I: Mitochondrial dysfunction disrupts
trafficking of Kir4.1 in spiral ganglion satellite cells. J Neurosci Res 2009,
87(1):141–149.
32. Zou J: Transport augmentation through the blood-inner ear barriers of
guinea pigs treated with 3-nitropropionic acid and patients with acute
hearing loss, visualized with 3.0 T MRI: figure labeling clarification. Otol
Neurotol 2012, 33(5):691.
33. Zou J, Zhang Y, Zhang W, Poe D, Zhai S, Yang S, Pyykko I: Mitochondria toxin-
induced acute cochlear cell death indicates cellular activity-correlated energy
consumption. Eur Arch Otorhinolaryngol 2013, 270(9):2403–2415.
34. Reuther R: NANOVALID Report Summary. 2013. http://cordis.europa.eu/
result/rcn/140307_en.html
35. Viberg A, Canlon B: The guide to plotting a cochleogram. Hear Res 2004,
197(1–2):1–10.
36. Johnson TA, Brown CJ: Threshold prediction using the auditory steady-state
response and the tone burst auditory brain stem response: a within-subject
comparison. Ear Hear 2005, 26(6):559–576.
37. Ngo JK, Pomatto LC, Davies KJ: Upregulation of the mitochondrial Lon
Protease allows adaptation to acute oxidative stress but dysregulation is
associated with chronic stress, disease, and aging. Redox Biol 2013,
1(1):258–264.
38. van Aerle R, Lange A, Moorhouse A, Paszkiewicz KH, Ball K, Johnston BD,
de-Bastos E, Booth T, Tyler CR, Santos EM: Molecular Mechanisms of Toxicity
of Silver Nanoparticles in Zebrafish Embryos. Environ Sci Technol 2013
Zou et al. Journal of Nanobiotechnology 2014, 12:52 Page 10 of 10
http://www.jnanobiotechnology.com/content/12/1/5239. Teodoro JS, Simoes AM, Duarte FV, Rolo AP, Murdoch RC, Hussain SM,
Palmeira CM: Assessment of the toxicity of silver nanoparticles in vitro:
a mitochondrial perspective. Toxicol In Vitro 2011, 25(3):664–670.
40. Costa CS, Ronconi JV, Daufenbach JF, Goncalves CL, Rezin GT, Streck EL,
Paula MM: In vitro effects of silver nanoparticles on the mitochondrial
respiratory chain. Mol Cell Biochem 2010, 342(1–2):51–56.
doi:10.1186/s12951-014-0052-6
Cite this article as: Zou et al.: Toxicity of silver nanoparticle in rat ear
and BALB/c 3T3 cell line. Journal of Nanobiotechnology 2014 12:52.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
